Novadiscovery
Claudio Monteiro is an accomplished Executive Manager at Nova In Silico, leading content strategy since September 2012. With a strong background in the biomedical field, Claudio has held various roles at Novadiscovery, including R&D scientist and project manager, contributing to advancements in modeling and simulation. Prior experiences include scientific research internships at CNRS, focusing on transcriptomic data analysis and pharmacokinetic-pharmacodynamic modeling. Claudio holds a PhD in Biomathematics, Bioinformatics, and Genomics, as well as a Master's degree in Public Health with a focus on pharmacology, and a Bachelor's degree in Biology with an emphasis on mathematics and computer science.
Novadiscovery
novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enablingscientists and biotech, pharma companies to predict drug efficacy and create the target combination.